Skip to main content

Day: April 26, 2024

Information relating to the total number of voting rights and shares making up the share capital at 26 April 2024 – post blocs acquisition by the Consortium

Information relative au nombre total de droits de vote et d’actions composant le capital social au 26 avril 2024 – après acquisition des blocs par le ConsortiumInformation relating to the total number of voting rights and shares making up the share capitalat 26 April 2024 – post blocs acquisition by the Consortium Articles L 233-8 II du Code de commerce et 223-16 du Règlement général de l’Autorité des marchés financiers Articles L 233-8 II of the French Commercial Code and 223-16 of the AMF General Regulations Place de cotation : NYSE Euronext-Paris Compartiment : Eurolist BCode ISIN : FR0014003FE9Date d’arrêté des informations   Declaration date Nombre total d’actions composant le capital social   Total number of shares in the share capital   Nombre total de droits de vote     Total number of voting rights26 avril 2024April 26,...

Continue reading

Offentliggørelse af prospekt samt formue og investorer for afdelingen HP Invest Bolig i Investeringsforeningen Wealth Invest

Hermed offentliggøres prospekt samt formue og antal investorer for afdelingen HP Invest Bolig, som optages til handel på Nasdaq Copenhagen A/S med første handelsdag 30. april 2024. Afdelingen har en formue på DKK 149.760.924 og 22 navnenoterede investorer. Hvis der måtte være spørgsmål i relation til ovenstående, kan der rettes henvendelse til direktør i Investeringsforvaltningsselskabet SEBinvest A/S, Lise Bøgelund Jensen på telefon 3328 2828.  Med venlig hilsen Investeringsforeningen Wealth InvestAttachment2024 04 26 Prospekt WI HP Invest Bolig_final

Continue reading

Konsolidator maintains its financial expectations for 2024

Company announcement no 8-2024 Søborg, April 26, 2024 Konsolidator maintains its financial expectations for 2024In Q1 2024, Konsolidator delivered ARR growth of 4% (YoY). The focus has been on establishing our Iberia sales office and preparing and launching the growth initiatives, including the new Microsoft D365 partner channel. Improving churn and increasing direct sales remain top priorities together with the growth initiatives. Konsolidator maintains its financial expectations of DKK 24-28m in ARR in 2024. 2024 is well underway, and Konsolidator has signed 7 new customers. However, Konsolidator has also lost 11 customers during Q1 2024m, thus churn has the utmost attention. Konsolidator expects to see an improvement in churn in the second half of 2024. In Q1 2024, Konsolidator initiated a Customer Success academy, which will be implemented...

Continue reading

Adevinta (ASA) publishes its 2023 Annual Report

Oslo, 26 April 2024 – Adevinta ASA today released its 2023 Annual Report, available here. A printed copy may be obtained free of charge upon written request to: ir@adevinta.com. Reflecting on 2023, Antoine Jouteau, CEO, said: “Over the past year, we have made significant progress on redesigning our operating model, verticalising our organisation in line with our Growing At Scale strategy and successfully completing our portfolio optimisation. We have achieved strong financial and operational performance in 2023 and continued to deliver against our targets, despite the tough macroeconomic environment. Following the divestment of our Hungarian classifieds business, our portfolio is now centred around our core European markets of France, Germany, Spain, Italy and Benelux, complemented by Canada and our joint ventures. We are delivering significant...

Continue reading

Medigene AG reports Financial Results and Business Update for Q1 2024

Planegg/Martinsried, April 26, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today reported financial results for the first quarter of 2024. The full Quarterly Statement Q1 2024 can be downloaded here: https://medigene.com/investors-media/reports-presentations/. “During the first quarter of 2024, our focus remained on executing our strategic plan and advancing the development of our unique TCR-T therapies for solid tumors, such as our lead program MDG1015,” said Selwyn Ho, CEO at Medigene. “While our core expertise lies in generating optimal TCRs, we are also exploring ways to broaden their application beyond TCR-T cell therapies.” “The recently announced capital...

Continue reading

Spar Nord repays Tier 2 capital with ISINs DK0030431341 and DK0030432075

Company announcement no. 29 It is hereby announced that Spar Nord has received the permission of the Danish Financial Supervisory Authority to repay bond loans (ISIN DK0030431341) for DKK 150 million and (ISIN DK0030431341) for DKK 350 million, currently both classified as Tier 2 capital. The repayment will take place on 29 May 2024. Please direct any questions regarding this release to Rune Brandt Børglum, Head of Investor Relations, on tel. + 45 9634 4236, or by e-mail at rsn@sparnord.dk. Rune Brandt BørglumHead of Investor RelationsAttachmentNo. 29 – Spar Nord repays Tier 2 capital – UK

Continue reading

Completion of capital reduction in Spar Nord Bank A/S

        Company announcement no. 28            As stated in company announcement no. 22, it was decided at Spar Nord Bank A/S’ ordinary general meeting on 19 March 2024 to reduce the company’s share capital by DKK 27,645,950 nominal value divided into 2,764,595 shares of DKK 10 through the cancellation of treasury shares. The capital reduction was published via the Danish Business Authority’s IT system on 26 March 2024. The statutory notice period has expired with no claims received. The capital reduction has been finally registered with the Danish Business Authority on 25 April 2024. After the capital reduction, the share capital of Spar Nord Bank A/S amounts to DKK 1,177,020,310 nominal value divided into shares of DKK 10 each. Pursuant to section 32 of the Danish Capital Markets Act, we hereby announce that the company’s...

Continue reading

Fluxys hydrogen appointed as “Hydrogen Network Operator” in Belgium

Brussels – 26 April 2024 – Implementing the Federal Hydrogen Act of 11 July 2023, Federal Energy Minister Tinne Van der Straeten has appointed Fluxys hydrogen, a subsidiary of Fluxys Belgium, as operator for the development and management of a hydrogen transmission grid in Belgium. The appointment as “HNO” – Hydrogen Network Operator – for Belgium is a major step forward in the energy transition. Leveraging Fluxys’ decades of expertise in gas transport, Fluxys hydrogen will develop the necessary infrastructure for transporting hydrogen, an essential component to reach the climate targets. In accordance with the federal hydrogen strategy, Fluxys hydrogen will undertake the development and operation of a hydrogen pipeline network, which will be part of the “European Hydrogen Backbone”. This will enable...

Continue reading

Yara reports increased deliveries, lower prices and reduced GHG emission intensity in 1Q

First-quarter EBITDA1 was USD 435 million compared to USD 487 million in first quarter 2023. Net income was USD 16 million (USD 0.07 per share) compared with USD 105 (USD 0.41 per share) a year earlier. First-quarter 2024 highlights:EBITDA1 down 11% from 1Q23 mainly due to lower prices Total deliveries up 12% with European deliveries up 37% from 1Q23 Reduced GHG emission intensity with implementation of key projects Healthy demand growth and limited capacity additions indicate tightening supply-demand balance longer term“This quarter’s results are down from same quarter last year as increased deliveries are offset by lower prices. Meanwhile, I am pleased to see that our efforts to decarbonize is yielding results. This is crucial to future-proof our business and be able to meet growing demand for low-carbon solutions”, said Svein...

Continue reading

Information relating to the total number of voting rights and shares making up the share capital on 25th of April 2024

Information relative au nombre total de droits de vote et d’actions composant le capital social au 25 avril 2024 Information relating to the total number of voting rights and shares making up the share capitalat 25 April 2024 Articles L 233-8 II du Code de commerce et 223-16 du Règlement général de l’Autorité des marchés financiers Articles L 233-8 II of the French Commercial Code and 223-16 of the AMF General Regulations Place de cotation : NYSE Euronext-Paris Compartiment : Eurolist BCode ISIN : FR0014003FE9Date d’arrêté des informations   Declaration date Nombre total d’actions composant le capital social   Total number of shares in the share capital   Nombre total de droits de vote     Total number of voting rights25 avril 2024April 25, 2024 97 161 351 Nombre théorique des droits de vote (1)Number...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.